So, with this, and with the sale of excellagen on hold in VA hospitals, what is the actual expectations of sales for it in China and Southeast Asia and possible revenues for Generex and when would such sales and revenue start to take place since deal has been signed?

This is what we should be seeing answered for the market as well currently.